Elanco Animal Health (United States) is listed on the Nasdaq and has a market capitalization of $11.62 billion, with shareholders equity totaling $6.59 billion.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Elanco Animal Health reported $5.02 billion in revenue, generating net income of $-199.00 million.
Key financial metrics include a P/E ratio of -58.40, a price-to-book (P/B) ratio of 1.76, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ELAN.